Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Indonesia Index ETF Market Vectors | IDX | Mar 17, 2025 | 13.00 | +0.73 |
Indonesia Invstble Mkt Idx MSCI Ishares | EIDO | Mar 17, 2025 | 16.62 | +0.30 |
Indust/Producer Dur Alphadex First Trust | FXR | Mar 17, 2025 | 70.87 | +1.30 |
Industrial Logistics Properties Trust | ILPT | Mar 17, 2025 | 3.59 | +2.87 |
Industrial Select Sector SPDR | XLI | Mar 17, 2025 | 132.94 | +1.38 |
Industrials ETF Vanguard | VIS | Mar 17, 2025 | 251.90 | +1.32 |
Infinera | INFN | Mar 17, 2025 | 6.64 | 0.00 |
InflaRx N.V | IFRX | Mar 17, 2025 | 1.22 | +2.52 |
Inflection Point Acquisition II | IPXX | Mar 17, 2025 | 10.79 | 0.00 |
Inflection Point Acquisition II Unit | IPXXU | Mar 17, 2025 | 10.57 | 0.00 |
Infobird | IFBD | Mar 17, 2025 | 1.64 | +3.14 |
Informatica | INFA | Mar 17, 2025 | 18.42 | +0.71 |
Information Services Group | III | Mar 17, 2025 | 3.50 | +4.32 |
Information Technology ETF Vanguard | VGT | Mar 17, 2025 | 566.35 | +0.59 |
Infosys ADR | INFY | Mar 17, 2025 | 18.57 | +0.92 |
InfuSystems | INFU | Mar 17, 2025 | 5.75 | +3.60 |
ING Group ADR | ING | Mar 17, 2025 | 20.28 | +0.10 |
Ingersoll Rand | IR | Mar 17, 2025 | 82.97 | +1.34 |
Ingevity | NGVT | Mar 17, 2025 | 44.23 | +0.64 |
Ingles Markets A | IMKTA | Mar 17, 2025 | 62.56 | +1.57 |
Ingram Micro Holding Corp | INGM | Mar 17, 2025 | 19.23 | +0.58 |
Ingredion | INGR | Mar 17, 2025 | 133.23 | +1.48 |
Inhibikase Therapeutics | IKT | Mar 17, 2025 | 2.36 | +4.89 |
Inhibrx Biosciences | INBX | Mar 17, 2025 | 13.94 | -1.13 |
INLIF | INLF | Mar 17, 2025 | 1.74 | 0.00 |
InMed Pharmaceuticals | INM | Mar 17, 2025 | 2.74 | -2.84 |
InMode | INMD | Mar 17, 2025 | 18.35 | +0.22 |
INmune Bio | INMB | Mar 17, 2025 | 7.67 | -3.52 |
Innate Pharma ADR | IPHA | Mar 17, 2025 | 2.02 | +1.00 |
Inno Holdings | INHD | Mar 17, 2025 | 4.40 | -7.56 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.